Master 2

The training provided thoughout the second year of the CTD graduate programme consists in the consolidation of the knowledge acquired during the first year, with the goal of achieving a level of expertise in the field of connective tissue diseases.
Students develop and strengthen this theoretical expertise through a solid clinical and scientific training within a renowned network of excellence.
This immersive professional experience within an international clinical and scientific crew will further facilitate the acquisition of transversal and intercultural skills.

Year two:

  • EULAR online course on systemic scleroderma – SSc: 100h / 8 ECTS
  • EULAR online course on paediatric rheumatology: 80h / 8 ECTS
  • EULAR online course on Systemic Lupus Erythematosus - SLE: 100h / 8 ECTS
  • two seminars on systemic scleroderma – network of reference and expertise centres for rare diseases: 40h / 3 ECTS
  • 10 webinars on auto-immune diseases (FAI2R) : 30h / 3 ECTS
  • French as a foreign language (or scientific English for French-speaking students): 20h / 2 ECTS
  • six months’ professional training within a hospital department accredited by the European Union (ERN ReCONNET network) followed by a thesis and the defense of a clinical research project presented as an article ready for submission: 28 ECTS

Training M2

Download the sheet of UE 1 

Modules :

  • 1. Introduction module:
    • Systemic sclerosis.
    • Localised scleroderma.
    • Epidemiology.
    • Activity.
    • The natural history of systemic sclerosis andassessment of diseaseseverity and damage.
  • 2. Pathogenesis:
    • Synthesis: early and late pathological events in scleroderma.
    • Vascular disease in systemic sclerosis (SSc).
    • Synthesis: Fibrosis is systemic sclerosis.
    • Immunological changes in systemic sclerosis.
    • Autoantibodies, autoimmunity.
    • The genetics of systemic sclerosis.
  • 3. Clinical manifestations: Skin, peripheral vascular.
    • Skin involvement.
    • Raynaud's phenomenon.
    • Microvascular andmacrovascular disease insystemic sclerosis.
  • 4. Heart involvement.
  • 5. Pulmonary interstitial/vascular involvement.
  • 6. Clinical manifestations: GI.
  • 7. Clinical manifestations: kidneyClinical characteristics and biopsy.
  • 8. Clinical manifestations: musculoskeletal, disability.
  • 9. Management.
  • 10. Special conditions. 

Download the sheet of UE 3 

Modules :

  • 1. General aspects of childhood and adolescence
  • 2. JIA 1 pathogenesis and clinical aspects
  • 3. JIA 2 treatment
  • 4. Childhood-onset Systemic Lupus Erythematosus and Related Disease
  • 5. Juvenile dermatomyositis
  • 6. Juvenile scleroderma
  • 7. Vasculitis
  • 8. Infectious and post-infectious arthritis
  • 9. Autoinflammatory Diseases
  • 10. Differential Diagnosis 1: Inflammatory Diseases
  • 11. Differential Diagnosis 2: Non inflammatory causes of musculoskeletal pain